• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性心绞痛中,“最大剂量”药物治疗不一定是最佳的。

"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris.

作者信息

Tolins M, Weir E K, Chesler E, Pierpont G L

出版信息

J Am Coll Cardiol. 1984 Apr;3(4):1051-7. doi: 10.1016/s0735-1097(84)80366-6.

DOI:10.1016/s0735-1097(84)80366-6
PMID:6707342
Abstract

Beta-adrenergic blocking agents, nitrates and calcium channel antagonists are effective in treating angina pectoris, but much remains unknown about how they act in combination. Consequently, treadmill exercise was used to assess the relative efficacy of nifedipine or isosorbide dinitrate, or both, in 19 patients with stable angina receiving propranolol. Propranolol therapy was continued and either placebo, nifedipine (20 mg), isosorbide dinitrate (20 mg) or both drugs were given randomly 1 1/2 hours before exercise in a double-blind trial. In 16 patients who completed the protocol, heart rate at rest during propranolol therapy was 53.7 +/- 1.9 beats/min (mean +/- standard error of the mean); it increased 4.6 +/- 1.2 beats/min with the addition of nifedipine (p less than 0.01), but was unchanged with isosorbide dinitrate or both combined. Compared with values during treatment with propranolol alone, systolic blood pressure at rest decreased with each vasodilator individually and when combined. Rate-pressure product at maximal exercise was the same with all combinations. Exercise duration was 467 +/- 50 seconds with propranolol, increased to 556 +/- 47 seconds with isosorbide dinitrate (p less than 0.05) and to 636 +/- 50 seconds with nifedipine (p less than 0.001). Exercise duration with all three drugs was 597 +/- 47 seconds (p less than 0.01 compared with propranolol alone). The improvement with nifedipine was greater than with isosorbide dinitrate (p less than 0.05) but exercise duration was not significantly different with the combination of these drugs than when either drug was used alone.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

β-肾上腺素能阻滞剂、硝酸盐类和钙通道拮抗剂在治疗心绞痛方面有效,但它们联合使用时的作用机制仍有很多未知之处。因此,采用跑步机运动来评估硝苯地平或硝酸异山梨酯或两者联合应用于19例接受普萘洛尔治疗的稳定型心绞痛患者的相对疗效。在一项双盲试验中,继续给予普萘洛尔治疗,并在运动前1个半小时随机给予安慰剂、硝苯地平(20毫克)、硝酸异山梨酯(20毫克)或两种药物。在完成方案的16例患者中,普萘洛尔治疗期间静息心率为53.7±1.9次/分钟(平均值±平均标准误差);加用硝苯地平后心率增加4.6±1.2次/分钟(p<0.01),但硝酸异山梨酯或两者联合应用时心率无变化。与单独使用普萘洛尔治疗时的值相比,每种血管扩张剂单独使用及联合使用时静息收缩压均降低。最大运动时的心率-血压乘积在所有组合中相同。普萘洛尔治疗时运动持续时间为467±50秒,硝酸异山梨酯治疗时增加至556±47秒(p<0.05),硝苯地平治疗时增加至636±50秒(p<0.001)。三种药物联合使用时运动持续时间为597±47秒(与单独使用普萘洛尔相比p<0.01)。硝苯地平的改善效果大于硝酸异山梨酯(p<0.05),但这些药物联合使用时的运动持续时间与单独使用任一药物时相比无显著差异。(摘要截短至250字)

相似文献

1
"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris.在慢性心绞痛中,“最大剂量”药物治疗不一定是最佳的。
J Am Coll Cardiol. 1984 Apr;3(4):1051-7. doi: 10.1016/s0735-1097(84)80366-6.
2
Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris.硝苯地平与硝酸异山梨酯在稳定型心绞痛中加至最大剂量普萘洛尔治疗时的比较。
Am J Cardiol. 1987 Aug 1;60(4):256-61. doi: 10.1016/0002-9149(87)90223-2.
3
Nifedipine and isosorbide dinitrate alone and in combination for patients with chronic stable angina: a double-blind crossover study.硝苯地平与硝酸异山梨酯单独及联合应用于慢性稳定型心绞痛患者:一项双盲交叉研究。
Am Heart J. 1990 Aug;120(2):303-7. doi: 10.1016/0002-8703(90)90073-7.
4
Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol.
Am J Cardiol. 1989 Sep 19;64(11):27F-30F. doi: 10.1016/0002-9149(89)90742-x.
5
Double-blind crossover comparison of the antianginal effects of nifedipine and isosorbide dinitrate in patients with exertional angina receiving propranolol.硝苯地平与硝酸异山梨酯对正在服用普萘洛尔的劳力型心绞痛患者抗心绞痛作用的双盲交叉比较。
J Am Coll Cardiol. 1985 Dec;6(6):1395-401. doi: 10.1016/s0735-1097(85)80231-x.
6
Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.硝苯地平与硝酸异山梨酯治疗慢性稳定性心绞痛的抗心绞痛疗效比较:一项长期、随机、双盲、交叉研究。
Am J Cardiol. 1985 May 17;55(12):9E-14E. doi: 10.1016/0002-9149(85)91205-6.
7
The effects of antianginal drugs on left ventricular function in patients with effort angina pectoris. Comparison among isosorbide dinitrate, nifedipine and propranolol by PANOVA.抗心绞痛药物对劳力型心绞痛患者左心室功能的影响。通过多因素方差分析比较硝酸异山梨酯、硝苯地平和普萘洛尔。
Jpn Heart J. 1988 Jan;29(1):19-33. doi: 10.1536/ihj.29.19.
8
Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study.硝苯地平、维拉帕米和硝酸异山梨酯在接受普萘洛尔治疗的患者中的抗心绞痛疗效比较:一项双盲研究。
Circulation. 1983 Sep;68(3):568-75. doi: 10.1161/01.cir.68.3.568.
9
Randomized double-blind comparison of nifedipine and isosorbide dinitrate in patients with coronary arterial spasm.硝苯地平与硝酸异山梨酯治疗冠状动脉痉挛患者的随机双盲对照研究
Am J Cardiol. 1982 Feb 1;49(2):431-8. doi: 10.1016/0002-9149(82)90521-5.
10
[Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent].
G Ital Cardiol. 1977;7(12):1162-71.

引用本文的文献

1
Combination and triple therapy in patients with stable angina pectoris not adequately controlled by optimal β-blocker therapy.在稳定型心绞痛患者中,联合治疗和三联疗法对经最佳β受体阻滞剂治疗后控制不佳的情况。
Neth Heart J. 2002 Nov;10(11):455-461.
2
Selection of optimal therapy for chronic stable angina.慢性稳定型心绞痛最佳治疗方法的选择。
Curr Treat Options Cardiovasc Med. 2006 Feb;8(1):23-35. doi: 10.1007/s11936-006-0023-9.
3
Contemporary management of chronic stable angina.慢性稳定型心绞痛的当代管理
Drugs Aging. 2001;18(2):109-21. doi: 10.2165/00002512-200118020-00004.
4
Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.氨氯地平或阿替洛尔单药治疗与联合治疗稳定型心绞痛的比较。
Clin Cardiol. 2000 Oct;23(10):763-70. doi: 10.1002/clc.4960231014.
5
Choosing the most appropriate treatment for stable angina. Safety considerations.为稳定型心绞痛选择最合适的治疗方法。安全性考量。
Drug Saf. 1998 Jul;19(1):23-44. doi: 10.2165/00002018-199819010-00003.
6
[Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy].[终末期冠心病的保守治疗方法。慢性间歇性尿激酶治疗]
Herz. 1997 Oct;22(5):262-71. doi: 10.1007/BF03044254.
7
The need for invasive cardiological assessment and operation: viewpoint of a district general hospital.侵入性心脏评估与手术的必要性:一家区综合医院的观点
Br Heart J. 1986 May;55(5):488-93. doi: 10.1136/hrt.55.5.488.
8
Combination of nitrates with other antianginal drugs.硝酸盐与其他抗心绞痛药物的联合使用。
Drugs. 1987;33 Suppl 4:43-8. doi: 10.2165/00003495-198700334-00009.
9
Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.钙通道拮抗剂。第四部分:副作用、禁忌、药物相互作用及联合用药
Cardiovasc Drugs Ther. 1988 Jul;2(2):177-89. doi: 10.1007/BF00051233.
10
The combination of antianginal drugs: effects and indications.抗心绞痛药物的联合应用:作用与适应证
Cardiovasc Drugs Ther. 1988 May;2(1):47-60. doi: 10.1007/BF00054252.